Results 111 to 120 of about 47,470 (225)

Machine Learning‐Based Prediction of Drug‐Induced QTc Changes in a Large Finnish Biobank Cohort

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Prolongation of the QT interval is a known precursor to serious arrhythmias and sudden cardiac death, often triggered by medication use. Current medication risk evaluation platforms rely on literature‐based synthesis and may lag behind real‐world developments.
Ville Langén   +7 more
wiley   +1 more source

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen

open access: yesVascular Health and Risk Management, 2008
Bimal V Patel1, R Scott Leslie1, Patrick Thiebaud1, Michael B Nichol2, Simon SK Tang3, Henry Solomon3, Dennis Honda3, JoAnne M Foody41MedImpact Healthcare Systems, Inc., San Diego, CA, USA (Patrick Thiebaud was an employee of MedImpact Healthcare Systems,
Bimal V Patel   +5 more
doaj  

Zero crossing and ratio spectra derivative spectrophotometry for the dissolution tests of amlodipine and perindopril in their fixed dose formulations

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2014
Dissolution tests of amlodipine and perindopril from their fixed dose formulations were performed in 900 mL of phosphate buffer of pH 5.5 at 37°C using the paddle apparatus.
Maczka Paulina   +3 more
doaj   +1 more source

Non-equivalence of antibiotic generic drugs and risk for intensive care patients [PDF]

open access: yes, 2013
Background: The underlying axiom in applying generic drugs is the equivalence of their active ingredient with the (usually more expensive) innovator product, an all-embracing statement with the insidious result that physicians assume that the generic ...
Barbeck, Mike   +4 more
core  

Transjugular Leadless Pacemaker Implantation in an Adolescent With Central Hypoventilation Syndrome: A Case Report

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 5, Page 606-609, May 2026.
ABSTRACT Background Permanent pacing in pediatric patients is complicated by small body size, vascular access limitations, and the need for durable long‐term management. Leadless pacemakers offer an emerging alternative that minimizes infection and lead‐related complications, yet vascular access remains a key challenge in young patients.
Marzia Giaccardi   +4 more
wiley   +1 more source

Profil Penggunaan Obat Pasien Hipertensi Esensial di Instalasi Rawat Jalan Rumah Sakit Umum Daerah I Lagaligo Kabupaten Luwu Timur Periode Januari-Desember Tahun 2014: Profile Of Drug Use In Patients With Essential Hypertension At Outpatient Installation General Hospital I Lagaligo Luwu Timur Regency Period Of January-December 2014 [PDF]

open access: yes, 2017
This study aimed to determine the demographic and clinical characteristics and profile of drug use in patients with essential hypertension at outpatient installations I Lagaligo General Hospital East Luwu Regency period January-December 2014.
Faustine, I. (Ingrid)   +2 more
core  

ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease [PDF]

open access: yes, 2016
Adams LG   +19 more
core   +1 more source

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. [PDF]

open access: yes, 2018
Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Johansen, Kirsten L   +4 more
core  

L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure

open access: yesClinical and Experimental Hypertension
Amlodipine has been used as a front-line anti-hypertensive therapy for decades by virtue of blocking voltage-operated calcium channels with high affinity and specificity.
Gary S. Bird   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy